- Home
- ATXS vs ORRF Comparison
ATXS vs ORRF Comparison
Compare ATXS & ORRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATXS | ORRF |
|---|---|---|
| Founded | 2008 | 1919 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 722.1M | 737.4M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | ATXS | ORRF |
|---|---|---|
| Price | $12.96 | $37.91 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 1 |
| Target Price | $24.33 | ★ $42.00 |
| AVG Volume (30 Days) | ★ 1.3M | 291.8K |
| Earning Date | 11-12-2025 | 01-30-2026 |
| Dividend Yield | N/A | ★ 2.86% |
| EPS Growth | N/A | ★ 198.98 |
| EPS | N/A | ★ 3.78 |
| Revenue | $706,000.00 | ★ $247,296,000.00 |
| Revenue This Year | N/A | $26.82 |
| Revenue Next Year | N/A | $2.18 |
| P/E Ratio | ★ N/A | $10.00 |
| Revenue Growth | N/A | ★ 66.90 |
| 52 Week Low | $3.56 | $25.57 |
| 52 Week High | $13.29 | $39.39 |
Technical Indicators
Market Signals| Indicator | ATXS | ORRF |
|---|---|---|
| Relative Strength Index (RSI) | 65.58 | 71.58 |
| Support Level | $12.70 | $37.63 |
| Resistance Level | $13.29 | $38.38 |
| Average True Range (ATR) | 0.22 | 0.63 |
| MACD | -0.05 | 0.15 |
| Stochastic Oscillator | 67.34 | 86.39 |
Price Performance
Historical ComparisonAbout ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About ORRF Orrstown Financial Services Inc
Orrstown Financial Services Inc is a holding company engaged in commercial banking and trust business, this involves accepting demand, time, and savings deposits and granting loans. The company is also engaged in lending services for commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services that include checking, savings, time, and money market deposits. It also provides investment and brokerage services through its Financial Advisors division. The Company earns fees from its deposit clients for transaction-based account maintenance and overdraft services, It also earns wealth management and investment brokerage fees from its contracts with trusts. The company operates in a segment, namely Community Banking.